Anemia: all 1,768 studies
Page 16 of 18. Open to participants first (244), then studies with results posted, then the rest; newest registration first within each.
- A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.CompletedNCT00560274Phase 4
- Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid TumorsCompletedNCT00559195Phase 2
- Anaemia Correction in Haemodialyzed Patients - Comparative Analysis of Two Erythropoietin Stimulating Agents SchedulesWithdrawnNCT00551603Phase 4
- Measurements of Anemia and Physiologic Tissue Response to Blood Transfusions in VLBW Infants Using Quantitative NIRSCompletedNCT00544375
- Safety and Efficacy of Sustained Erythropoietin TherapyCompletedNCT00542568Phase 1/2
- Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle ChemotherapyCompletedNCT00540384Phase 1/2
- Tadalafil for Treatment of Priapism in Men With Sickle Cell AnemiaWithdrawnNCT00538564Phase 2
- Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical HypothyroidismCompletedNCT00535561Phase 1
- An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) TrialTerminatedNCT00534456Phase 3
- Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic DisordersCompletedNCT00533923Phase 2
- Erythropoietin Resistance in Anemia of Chronic Kidney DiseaseCompletedNCT00526747
- Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving ChemotherapyCompletedNCT00524407Phase 4
- Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)CompletedNCT00520780Phase 3
- Hydroxyurea in Young Children With Sickle Cell AnemiaCompletedNCT00519701Not applicable
- Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic AnemiaCompletedNCT00513175
- Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00512564
- Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00512226Not applicable
- Effectiveness of Iron-Fortified Milk on Iron Status and Anemia in Young Children in MexicoCompletedNCT00508131Phase 3
- Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to TreatmentCompletedNCT00499070
- Gastrointestinal Evaluation in Young Men With Iron Deficiency AnemiaStatus unknownNCT00498511
- RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian InfantsTerminatedNCT00497471Not applicable
- RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related AnemiaTerminatedNCT00495378Phase 4
- A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.TerminatedNCT00495365Phase 4
- Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With CancerStatus unknownNCT00482716Phase 3
- Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced AnemiaWithdrawnNCT00481624Phase 2
- Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological PatientsCompletedNCT00478582Not applicable
- Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart DiseaseWithdrawnNCT00459225Not applicable
- A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human ErythropoietinCompletedNCT00456053Phase 2
- The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) DiseaseCompletedNCT00446576Phase 3
- A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.CompletedNCT00442793Phase 3
- A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.TerminatedNCT00440063Phase 4
- A Trial of 2 'Point of Care' Diagnostic Methods to Improve Detection and Treatment of Anaemia in African ChildrenCompletedNCT00439595Not applicable
- Hepcidin in Anemic Chronic Heart Failure (CHF) PatientsCompletedNCT00437866
- Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic AcidStatus unknownNCT00437450Phase 2
- Evaluation of an Intervention Program for the Prevention of AnemiaStatus unknownNCT00436202Not applicable
- Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of TreatmentCompletedNCT00414479
- The Israeli Trigger for Blood Transfusions in the ICUStatus unknownNCT00413816
- A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.CompletedNCT00413101Phase 4
- Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow VelocityCompletedNCT00402480Phase 2
- The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study)CompletedNCT00401869Phase 4
- Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic AnemiaStatus unknownNCT00399971Phase 1/2
- Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal FailureCompletedNCT00399269Phase 3
- A Test of Iron Malabsorption in Patients With Iron Deficiency AnemiaCompletedNCT00399191Phase 1
- Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell AnemiaCompletedNCT00399074Phase 3
- Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)CompletedNCT00398749
- Correction of Anaemia and Progression of Renal Failure on Transplanted PatientsCompletedNCT00396435Phase 4
- Flexible Administration of Sprinkles® in Infants and Young Children in Rural Bangladesh.CompletedNCT00392418Not applicable
- PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation TherapyCompletedNCT00388336Phase 2
- Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF StudyStatus unknownNCT00386126Phase 2/3
- Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney DiseaseWithdrawnNCT00384657Phase 3
- Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate CancerTerminatedNCT00381836Phase 2/3
- COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.CompletedNCT00377481Phase 4
- Low Bacterial Diet in Patients With CytopeniaCompletedNCT00367588Not applicable
- A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and WomenCompletedNCT00360425Phase 1
- A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid TumorCompletedNCT00359840Phase 2
- Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood TransplantTerminatedNCT00354419Phase 1
- A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy.TerminatedNCT00350090Phase 3
- A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer PatientsCompletedNCT00344409Phase 3
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesCompletedNCT00343798Phase 1
- A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy.CompletedNCT00341055Phase 3
- An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three WeeksCompletedNCT00338416Phase 2
- Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced AnemiaCompletedNCT00338299Phase 2
- Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative PatientsCompletedNCT00338234
- An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four WeeksCompletedNCT00337948Phase 2
- Treatment of Chronic Anemia With Epoetin Alfa in ElderlyStatus unknownNCT00337441Phase 2
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic AnemiaStatus unknownNCT00319878Phase 1/2
- Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's AnemiaCompletedNCT00317876Phase 1
- Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced AnemiaCompletedNCT00315484Phase 4
- Effects of Early Correction of Anemia in Patients With Chronic Renal InsufficiencyTerminatedNCT00312871Phase 4
- A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)CompletedNCT00307814Phase 2
- A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving ChemotherapyTerminatedNCT00306267Phase 2
- Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First RemissionCompletedNCT00305708Phase 1/2
- Etiology of AnemiaTerminatedNCT00302939
- Study on Preventing Anemia in Children in GhanaCompletedNCT00301054Not applicable
- Efficacy of Intravenous Iron Administration in Hemodialysis PatientsCompletedNCT00298441Phase 4
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerTerminatedNCT00290628Not applicable
- Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG InfantsCompletedNCT00285662Not applicable
- Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?CompletedNCT00284700Not applicable
- A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing ChemotherapyCompletedNCT00283465Phase 4
- Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory AnemiaCompletedNCT00278330Phase 1
- Bone Marrow Cell Gene Transfer in Individuals With Fanconi AnemiaCompletedNCT00272857Phase 1
- Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving ChemotherapyCompletedNCT00272662Phase 2
- Blood Cell Collection for Future Use in Individuals With Fanconi AnemiaCompletedNCT00271089Not applicable
- A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) TherapyCompletedNCT00270283Phase 2
- A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) TherapyCompletedNCT00270270Phase 2
- A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery.CompletedNCT00270179Phase 3
- The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving ChemotherapyCompletedNCT00270166Phase 3
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Facilitating the Presurgical Collection of Blood to be Used for Self-donation During Surgery on the Spine, Hip, or Knee.CompletedNCT00270140Phase 3
- Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum ChemotherapyCompletedNCT00270127Phase 3
- A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood)CompletedNCT00270114Phase 2/3
- The Effect of Epoetin Alfa on the Anemia of Patients With Multiple MyelomaCompletedNCT00270101Phase 3
- A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery.CompletedNCT00270088Phase 3
- A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery.CompletedNCT00270062Phase 3
- Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic LeukemiaCompletedNCT00270049Phase 2
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their DiseaseCompletedNCT00270010Phase 2
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy DrugCompletedNCT00269997Phase 2
- A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced CancerCompletedNCT00269984Phase 2
- A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.WithdrawnNCT00269971Phase 3
- A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement SurgeryCompletedNCT00269958Phase 2
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their DiseaseCompletedNCT00269945Phase 2